StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > 1 million shares on the OTC bid at 0.12 USD

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Oct 16, 2024 1:53pm

68 Views

Post# 36268537

RE:RE:1 million shares on the OTC bid at 0.12 USD

Anyone like to comment on the tsx likely opening over 400% up from the last trade price since the cto in the next couple weeks?? ;) what's 0.12 usd in canadian...like 0.16 hmmm and still a few weeks to go, wonder what it'll be by then:)

<< Previous

Bullboard Posts

Next >>

AI companies to invest in